Magnetic Bead Nucleic Acid Size Selection via Buffer Parameters

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for nucleic acid purification and fragment size selection in next-generation sequencing (NGS) are either labor-intensive, inaccurate, or unsuitable for larger DNA fragments, leading to sequencing bias and reduced data quality.

Innovation Solution

A method involving the use of chaotropic salts in a binding buffer to selectively bind and elute nucleic acid fragments of specific size ranges to a solid surface, such as a silica membrane filter column or silica-coated magnetic microparticles, allowing for precise control over fragment size and high recovery rates.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If agarose gel electrophoresis is used for size selection, then fragment size precision is improved, but processing speed and productivity deteriorate

Engineering Contradiction:
Improvefragment size precisionVSAvoidprocessing speed
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent replaces the mechanical agarose gel electrophoresis system with a magnetic bead-based separation system. Magnetic beads functionalized with carboxyl groups bind to DNA fragments in a buffer solution, allowing size selection through magnetic field manipulation rather than physical gel migration. This substitution enables automated liquid handling and magnetic separation, dramatically increasing throughput while maintaining size selection accuracy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes changes in buffer composition parameters (PEG concentration, salt concentration, pH) to control the binding affinity between magnetic beads and DNA fragments. By adjusting these parameters, the system selectively binds fragments within a specific size range (e.g., 150-500 bp for Illumina, 300-700 bp for other platforms), enabling precise size selection without gel electrophoresis. The binding buffer contains chaotropic salts that enhance DNA binding to the magnetic beads while the PEG creates size-selective conditions.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If PEG-based magnetic bead method is used, then productivity is improved, but fragment size control precision deteriorates for fragments larger than 400 bp

Engineering Contradiction:
ImprovethroughputVSAvoidfragment size control precision
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent optimizes the binding buffer composition with specific concentrations of PEG (e.g., 8-10% w/v), chaotropic salts (e.g., 0.5-2.0 M NaCl or KCl), and adjusts pH to 7.0-8.5 to enhance binding efficiency for larger DNA fragments. These parameter adjustments increase the binding affinity and capacity of magnetic beads for fragments in the 300-700 bp range, resolving the size control limitation of conventional methods while maintaining high throughput.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite magnetic beads with multiple functional components: magnetic core material (e.g., magnetite or γ-Fe2O3) for magnetic manipulation, carboxyl functional groups for DNA binding, and surface coatings for stability and size-selective interaction. This composite structure enables both high productivity through magnetic separation and improved size control for larger fragments through optimized surface chemistry and binding buffer composition.

Inventive Principle:
Principle #40Composite materials

3Speed

If conventional size selection methods are used, then processing speed is improved, but nucleic acid recovery yield deteriorates

Engineering Contradiction:
Improveprocessing speedVSAvoidnucleic acid recovery yield
Core Design Contradiction:
SpeedVSQuantity of substance

Solution Approach 1:

The patent employs elution buffers with optimized parameters including low salt concentration (e.g., 10-50 mM Tris-HCl, pH 8.0-8.5) and elevated temperature (e.g., 65-75°C) to maximize DNA release from magnetic beads. The low salt concentration reduces ionic shielding and weakens DNA-bead interactions, while heat provides thermal energy to disrupt hydrogen bonding. This combination achieves near-complete elution efficiency, maintaining high recovery yields despite the rapid processing speed enabled by magnetic separation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements a continuous magnetic bead workflow where beads are sequentially used for binding, washing, and elution without requiring gel extraction steps. The magnetic beads remain in suspension and are manipulated continuously through magnetic field application and removal, enabling rapid buffer exchanges and eliminating time-consuming gel cutting and purification steps. This continuous process maintains both high speed and high recovery by preventing DNA loss associated with gel manipulation.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a quick, high-throughput, and accurate means of nucleic acid purification and fragment size selection, enabling efficient recovery of desired DNA fragments, reducing sequencing bias, and improving data quality across various NGS platforms.

Implementation Method 1

mixing target nucleic acids with a binding buffer having a selected pH, and salt concentration to allow the nucleic acid fragments with a desired size range to be bound to a solid surface

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

selectively recovering the bound nucleic acid fragments with the desired size range by eluting the bound nucleic acid fragments from the solid surface with an eluting buffer

Methodology Applied
Scientific EffectDesorption: Desorption

Data Source

PatentUS9624252B2Selective nucleic acid fragment recovery
Publication Date: 2017.04.18 OMEGA BIO TEK
  • US9624252B2 patent drawing
  • US9624252B2 patent drawing
  • US9624252B2 patent drawing

AI summary

The invention provides methods and kits for nucleic acid purification and fragment selection and recovery. By adjusting salt concentrations and/or pH of the binding buffers, only nucleic acid fragments with desired size ranges are able to reversibly and non-specifically bind to a solid surface in certain salt concentrations and/or pH conditions, and can be subsequently eluted and/or recovered from the solid surface in water and/or a low salt eluting buffer.